Rapidly evolving Creutzfeldt–Jakob disease in COVID-19: from early status epilepticus to fatal outcome Olivo, S., Furlanis, G., Buoite Stella, A....
https://onlinelibrary.wiley.com/doi/10.1111/jth.14981 Parallels with systemic inflammatory disorders such as atypical hemolytic uremic syndrome...
Full title: SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and...
COVID-19 Neuropathology: evidence for SARS-CoV-2 invasion of Human Brainstem Nuclei Aron Emmi, Stefania Rizzo, Luisa Barzon, Michele Sandre, Elisa...
Premortem Skin Biopsy Assessing Microthrombi, Interferon I Antiviral and Regulatory Proteins, and Complement Deposition Correlates with...
Neurovascular injury with complement activation and inflammation in COVID-19 Myoung-Hwa Lee, Daniel P. Perl, Joseph Steiner, Nicholas Pasternack,...
Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain Preprint Abstract Survivors of...
SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery Justin J. Frere, Randal A....
Multi-Disciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Cardiovascular Complications in Patients with...
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00126-6/fulltext With the ongoing COVID-19 pandemic, growing evidence shows...
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes Edward Richardson, David García-Bernal,...
SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy (Non peer-reviewed) Jae Kyu Ryu, Elif G...
https://www.cell.com/med/fulltext/S2666-6340(22)00167-2 Highlights 1.Approximately half of COVID-19 patients shed fecal RNA in the week after...
moved thread The long covid groups seem to believe that long covid is often associated with mild initial disease and not having antibodies on...
Patients with coronavirus disease 2019 (COVID-19) frequently develop acute encephalopathy and encephalitis, but whether these complications are...
Title : N-Acetylcysteine to Combat COVID-19: An Evidence Review Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649937/ Abstract The novel...
Abstract Neurological manifestations are a significant complication of coronavirus disease (COVID-19), but underlying mechanisms aren’t well...
The Pfizer press release reports that protection is achieved 28 days after initiation of the first dose of vaccine. Whereas you can develop covid...
Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers Miguel...
Evaluation of science advice during the COVID-19 pandemic in Sweden Nele Brusselaers, David Steadson, Kelly Bjorklund, Sofia Breland, Jens...
Separate names with a comma.
